ICM
TMO icon

IMS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

IMS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$342K Sell
706
-140
-17% -$65.2K 0.16% 99
2025
Q2 		$343K Sell
846
-218
-20% -$91.1K 0.16% 104
2025
Q1 		$529K Sell
1,064
-75
-7% -$40.6K 0.27% 78
2024
Q4 		$593K Sell
1,139
-63
-5% -$34.6K 0.27% 72
2024
Q3 		$744K Sell
1,202
-5
-0.4% -$2.96K 0.33% 71
2024
Q2 		$742K Sell
1,207
-54
-4% -$30.9K 0.35% 70
2024
Q1 		$733K Hold
1,261
– – 0.34% 70
2023
Q4 		$669K Hold
1,261
– – 0.33% 75
2023
Q3 		$638K Hold
1,261
– – 0.38% 65
2023
Q2 		$658K Buy
1,261
+25
+2% +$13.5K 0.37% 67
2023
Q1 		$712K Buy
1,236
+20
+2% +$11.3K 0.42% 64
2022
Q4 		$670K Buy
1,216
+30
+3% +$15.9K 0.43% 72
2022
Q3 		$602K Buy
1,186
+54
+5% +$30.2K 0.42% 71
2022
Q2 		$615K Sell
1,132
-34
-3% -$18.7K 0.4% 71
2022
Q1 		$689K Buy
1,166
+475
+69% +$273K 0.36% 75
2021
Q4 		$461K Buy
691
+313
+83% +$195K 0.24% 89
2021
Q3 		$216K Buy
+378
New +$207K 0.13% 130
2018
Q4 		– Sell
-219
Closed -$53K – 330
2018
Q3 		$53K Buy
+219
New +$50.4K 0.04% 196

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IMS Capital Management's TMO Position: Q3 2025 in Review

IMS Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q3 2025, selling an estimated $65.2K and leaving 706 shares worth $342K. The position accounts for 0.16% of the portfolio, ranked #99.

IMS Capital Management first reported a position in TMO in Q3 2018 and has held it in 18 quarters since. The position peaked at $744K in Q3 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • IMS Capital Management held 706 shares of Thermo Fisher Scientific worth $342K as of Q3 2025.
  • IMS Capital Management sold 140 Thermo Fisher Scientific shares in Q3 2025, an estimated $65.2K.
  • Thermo Fisher Scientific made up 0.16% of IMS Capital Management's portfolio in Q3 2025, its #99 holding.
  • IMS Capital Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 18 quarters since.
  • IMS Capital Management's Thermo Fisher Scientific position peaked at $744K in Q3 2024.
  • 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.